Gsa Capital Partners LLP Clearside Biomedical, Inc. Transaction History

Gsa Capital Partners LLP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$1.3 - $2.49 $25,769 - $49,359	19,823 Added 25.33%	98,097 $144,000
Q1 2022 May 11, 2022	BUY	$1.35 - $2.88 $105,669 - $225,429	78,274 New	78,274 $179,000
Q1 2021 May 10, 2021	SELL	$2.24 - $4.25 $134,023 - $254,286	-59,832 Closed	0 $0
Q4 2020 Feb 03, 2021	BUY	$1.32 - $2.74 $8,758 - $18,179	6,635 Added 12.47%	59,832 $164,000
Q3 2020 Nov 06, 2020	SELL	$1.45 - $2.0 $1,297 - $1,790	-895 Reduced 1.65%	53,197 $82,000
Q2 2020 Aug 11, 2020	BUY	$1.55 - $2.41 $83,842 - $130,361	54,092 New	54,092 $102,000
Q3 2019 Nov 12, 2019	SELL	$0.59 - $1.32 $74,940 - $167,663	-127,018 Closed	0 $0
Q2 2019 Aug 06, 2019	SELL	$0.97 - $1.42 $101,712 - $148,898	-104,858 Reduced 45.22%	127,018 $123,000
Q1 2019 May 15, 2019	BUY	$1.1 - $1.74 $123,052 - $194,646	111,866 Added 93.21%	231,876 $320,000
Q4 2018 Feb 12, 2019	BUY	$1.0 - $6.12 $20,000 - $122,400	20,000 Added 20.0%	120,010 $128,000
Q3 2018 Nov 13, 2018	BUY	$6.03 - $11.24 $302,103 - $563,124	50,100 Added 100.38%	100,010 $615,000
Q2 2018 Aug 09, 2018	BUY	$8.91 - $14.54 $444,698 - $725,691	49,910 New	49,910 $534,000
Q1 2018 May 11, 2018	SELL	$5.57 - $14.28 $70,182 - $179,928	-12,600 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$5.78 - $9.12 $298,248 - $470,591	-51,600 Reduced 80.37%	12,600 $88,000
Q3 2017 Nov 20, 2017	BUY	$6.73 - $8.74 $432,066 - $561,108	64,200	64,200 $561,000

12.2M

54.7K

50.7K

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $61.4M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.